Type 1 diabetes is an autoimmune disease affecting more than 1.6 million Americans and more the 21 million people around the world. People living with type 1 diabetes lose the ability to produce insulin, resulting in uncontrolled blood glucose levels.
Learn MoreIsla technologies harnesses the power of cells in a minimally invasive implant to secrete insulin automatically in response to sugar stimulus.
Our cellular implant will give people living with type 1 diabetes the freedom to live healthier live free from insulin injections.
Type 1 diabetes is an autoimmune disease affecting more than 1.6 million Americans and more the 21 million people around the world. People living with type 1 diabetes lose the ability to produce insulin, resulting in uncontrolled blood glucose levels.
Learn MoreIsla technologies harnesses the power of cells in a minimally invasive implant to secrete insulin automatically in response to sugar stimulus.
Our cellular implant will give people living with type 1 diabetes the freedom to live healthier live free from insulin injections.